Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CORRECTION: Exact Sciences Q3 Adj. EPS $0.24 Beats $(0.07) Estimate, Sales $850.739M Beat $810.178M Estimate

Author: Benzinga Newsdesk | November 03, 2025 05:46pm
Exact Sciences (NASDAQ:EXAS) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $(0.07) by 442.86 percent. This is a 242.86 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $850.739 million which beat the analyst consensus estimate of $810.178 million by 5.01 percent. This is a 20.05 percent increase over sales of $708.655 million the same period last year.

Posted In: EXAS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist